Literature DB >> 15109676

Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.

Cyrille Boussard1, Thomas Klimkait, Naheed Mahmood, Martin Pritchard, Ian H Gilbert.   

Abstract

This paper describes an approach to prevent HIV-cell fusion by disrupting the interaction between HIV protein gp120 and CD4 receptor. The CD4 residues Phe43 and Arg59 make important interactions with gp120. Small molecule analogues were made to mimic the crucial features of these residues. The analogues were assayed using a cellular 'FIGS' assay to measure inhibition of cell fusion and caused some inhibition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15109676     DOI: 10.1016/j.bmcl.2004.02.091

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

Review 2.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

3.  Interaction of monobenzamidine-linked trypanocides with the Trypanosoma brucei P2 aminopurine transporter.

Authors:  Mhairi L Stewart; Cyrille Boussard; Reto Brun; Ian H Gilbert; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.